Liver cyst penetration of antibiotics at the target site of infection: a randomized pharmacokinetic trial
NTR8499The trial was originally registered in the Netherlands Trial Register (ID: NL7290), which was converted to the International Clinical Trials Registry Platform in 2022.
Authors
- Nynke G L Jager (ORCID: https://orcid.org/0000-0002-4524-9892)
- Lucas H.P. Bernts (ORCID: https://orcid.org/0000-0003-0945-5004)
- Marten A. Lantinga (ORCID: https://orcid.org/0000-0003-3137-901X)
- Anouk M E Jansen (ORCID: https://orcid.org/0000-0002-4736-6515)
- Roger J. M. Brüggemann (ORCID: https://orcid.org/0000-0002-7618-725X)
- Heiman Wertheim (ORCID: https://orcid.org/0000-0002-5003-5565)
- Joost P.H. Drenth (ORCID: https://orcid.org/0000-0001-8027-3073)
Institutions
- Radboud University Nijmegen (NL)
- University Medical Center (US)
- Radboud University Medical Center (NL)
- ERN GUARD-Heart (NL)
- Amsterdam University Medical Centers (NL)
- ERN RARE-LIVER (DE)
- University of Amsterdam (NL)
Publication Details
- Journal
- Journal of Antimicrobial Chemotherapy
- Published
- 2024-11-07
- DOI
- https://doi.org/10.1093/jac/dkae394
- Primary Topic
- Liver Disease and Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Radboud Universiteit
- Radboud Universitair Medisch Centrum
- European Association for the Study of the Liver